Myopia Management Options: What Works, What the Data Shows, and How to Choose
Myopia is nearsightedness. Myopia management options are clinical strategies designed to slow the progression of nearsightedness in children. Without active intervention, myopia can worsen year after year, raising the risk of serious complications like glaucoma, early cataracts, retinal detachment and myopic macular degeneration well into adulthood.
Key Takeaways
Standard single-vision glasses correct myopia but do nothing to stop it from getting worse over time.
Specialty spectacle lenses, orthokeratology, MiSight lenses, and low-dose atropine have each shown roughly 40-60% reductions in axial elongation in published clinical trials, though results vary by method, concentration, and individual patient.
Increased outdoor time — at least two hours daily — offers a meaningful preventive benefit, especially for younger children.
Poor adherence is one of the most common reasons myopia management fails, so choosing a method your child will actually stick with matters as much as raw efficacy.
Axial length measurement is increasingly used alongside standard refraction to track progression, giving a more precise picture of how a child's eyes are changing over time.
Why Standard Glasses Are Not Enough for a Progressing Prescription
Many parents assume that updating their child's glasses prescription every year is simply part of growing up. It is not a given. According to the NIH National Eye Institute, myopia affects roughly one-third of the U.S. population, and prevalence is rising sharply in school-age children. Left unmanaged, high myopia significantly increases the lifetime risk of glaucoma, cataracts, retinal detachment, and myopic macular degeneration.
The core problem with standard glasses and conventional contact lenses is that they correct how your child sees today, but they do not address the underlying issue: the eye is physically elongating. That elongation, measured in millimeters of axial length, is what drives long-term risk. Myopia management is specifically designed to slow that elongation.
Specialty Glasses Designed to Slow Myopia Progression
Myopia-specific spectacle lenses are often the first line of intervention for younger children who are not yet ready for contact lenses. Two products have strong clinical backing:
Stellest® lenses (Essilor®): In the two-year US clinical trial, Stellest reduced myopia progression by 71% and axial elongation by 53% compared with single-vision lenses. In September 2025 it became the first spectacle lens to receive FDA market authorization for slowing myopia progression, approved for children aged 6 to 12 at the start of treatment.
Source: Bao J, Huang Y, Li X, et al. Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses: A Randomized Clinical Trial. JAMA Ophthalmol. 2022;140(5):472-478.
MiYOSmart lenses (Hoya): A two-year randomized trial found 59% less myopia progression and 60% less axial elongation versus single-vision lenses. This lens is not currently sold in the US.
Source: Lam CSY, Tang WC, Tse DY, et al. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomized clinical trial. Br J Ophthalmol. 2020;104(3):363-368.
Stellest lenses use tiny aspherical lens lets arranged in 11 concentric rings, while MiYOSmart uses roughly 400 circular defocus segments in a honeycomb pattern. Both redirect peripheral light in a way that signals the eye to slow its growth.
Soft Multifocal Contact Lenses for Active Kids and Teens
For children who are ready for contact lenses, soft multifocal designs offer a strong evidence base. The most studied option in the U.S. is CooperVision's MiSight 1 day, the first and only FDA-approved soft contact lens for slowing myopia progression, indicated for children aged 8 to 12 at the start of treatment. Clinical data from a three-year study showed approximately 52% less axial elongation and a 59% reduction in spherical equivalent refraction progression compared to single-vision lenses, and seven-year follow-up data shows the effect is sustained over time.
MiSight is a daily disposable — worn during the day and discarded each evening — which reduces hygiene concerns compared with reusable lenses. Note that not all soft multifocal designs are daily disposables; some are monthly or two-week replacement. These lenses work best for children who are motivated to wear contacts consistently. Compliance is critical: skipping days or shortening wear time meaningfully reduces the treatment benefit.
You can review the full range of specialty contact lens options available at Texas Contact Lens Institute by visiting their services page, which also covers scleral lens fitting and keratoconus management.
Orthokeratology: Corneal Reshaping While Your Child Sleeps
Orthokeratology (ortho-K) involves rigid gas-permeable lenses worn overnight that gently reshape the cornea. By morning, the child removes the lenses and sees clearly throughout the day without any daytime correction. The Retardation of Myopia in Orthokeratology (ROMIO) study and the HM-PRO trial both found reductions in axial elongation ranging from 43% to 63%.
Ortho-K is particularly well-suited for active children and teens who play sports or participate in swimming. It does require a more involved fitting process and a strict nightly cleaning routine. Parents and patients should understand the lens care commitment before starting. If you have questions about whether ortho-K is right for your child, the meet the doctor page at Texas Contact Lens Institute gives you a clear sense of the clinical expertise behind these fittings in Plano, TX.
Atropine Eye Drops: The Pharmacological Approach
Low-dose atropine remains one of the most well-researched pharmacological myopia management options. It is typically compounded at concentrations of 0.01% to 0.05% and applied once nightly. In the LAMP study, a randomized placebo-controlled trial of 438 children, all three low concentrations slowed myopia progression in a dose-dependent pattern, and 0.05% was the most effective of the low concentrations tested, exceeding 50% efficacy. Results have been less consistent in non-Asian populations, so an optometrist should assess whether it is appropriate for your child.
It is worth being aware that response to atropine varies by ethnicity and geographic population, so outcomes are not perfectly uniform across all children. Side effects at low doses are generally mild (slight light sensitivity and near blur) but should be discussed with your optometrist. Atropine is often used in combination with optical treatments for children with faster-progressing prescriptions.
Red Light Therapy: An Emerging Non-Invasive Option
Repeated low-level red-light (RLRL) therapy is a newer non-invasive approach gaining traction in U.S. clinics. The child looks into a handheld device for short sessions each day. Early studies, reviewed by the American Optometric Association, report meaningful reductions in axial elongation with a favorable safety profile, though long-term data over five or more years is still developing. It is considered a promising adjunct option, particularly for children who struggle with contact lens compliance.
Outdoor Time and Behavioral Strategies That Make a Real Difference
Before any clinical intervention, behavioral habits matter. Research consistently shows that increased outdoor time reduces the likelihood of myopia onset in children, with studied interventions ranging from 40 to 120 minutes daily. The protective mechanism appears to be exposure to high-intensity natural light stimulating dopamine release in the retina, which inhibits axial growth. The Centers for Disease Control and Prevention supports outdoor activity as a core element of children's health programs.
Source: He X, Sankaridurg P, Wang J, et al. Time Outdoors in Reducing Myopia: A School-Based Cluster Randomized Trial with Objective Monitoring of Outdoor Time and Light Intensity. Ophthalmology. 2022;129(11):1245-1254.
Reducing prolonged near work (screens, reading at close distances without breaks) also helps. These strategies are preventive rather than curative once myopia has started progressing, but they remain a valuable layer in any management plan.
How to Pick the Right Myopia Management Option for Your Child
There is no single best treatment. The right choice depends on:
Age and prescription strength: Glasses-based options suit younger children; contact lens options suit motivated pre-teens and teens.
Lifestyle: Ortho-K works well for athletes; daytime soft lenses suit children with consistent routines.
Rate of progression: Faster progressors often benefit from combination therapy (for example, atropine plus ortho-K).
Compliance likelihood: A less effective treatment your child actually uses beats a more effective one they abandon.
You can read current clinical perspectives on managing pediatric myopia on the blog at Texas Contact Lens Institute, and if your child's school or pediatrician wants to coordinate care, the practice also accepts referrals from other providers.
Things to Know
Myopia management is not a cure; it slows progression but does not reverse existing nearsightedness.
Most treatments show the greatest benefit when started early.
Stopping treatment too early can result in a rebound effect where progression resumes or accelerates.
Source: Yam JC, Zhang XJ, Zhang Y, et al. Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression Study: Continued Versus Washout. Ophthalmology. 2022;129(3):308-321.
Frequently Asked Questions
Q: At what age should myopia management begin?
Most specialists recommend starting as soon as progressive myopia is confirmed, typically between ages six and twelve.
Earlier intervention means more years of protection during the critical growth period.
Q: Can my child use more than one myopia management treatment at a time?
Yes, combination therapy is increasingly common and often more effective than any single treatment alone.
Pairing low-dose atropine with ortho-K, for example, may produce greater slowing of axial elongation than either treatment used independently. Your optometrist can assess whether a combination approach is appropriate.
Q: How long does myopia management treatment last?
Treatment typically continues until axial elongation stabilizes, which usually happens in the mid-to-late teens, but may be later as well.
Some children may need treatment through age 18 or beyond depending on their rate of progression. Stopping too soon risks a rebound in progression, so the timeline should be guided by your doctor, not a fixed schedule.
Q: Is orthokeratology safe for children?
Ortho-K has a strong safety record when lenses are properly fitted and hygiene protocols are followed consistently.
The primary risk is microbial keratitis, which is rare (5.4 in 10,000) and reduced with proper lens care. Regular follow-up appointments, typically every three to six months, allow your optometrist to monitor corneal health throughout treatment.
Q: How do I get started with myopia management at Texas Contact Lens Institute?
You can schedule an initial consultation directly through the practice's website or by calling their Plano, TX office at +1 972-299-8675.
The clinic is located at 6020 W Parker Rd Ste 260, Plano, TX 75093, and offers a full range of specialty services including orthokeratology, atropine therapy, and multifocal contact lens fitting. You can also reach them through the contact page on their website. Visit the home page for current hours and directions.
The Bottom Line on Myopia Management Options
The window for meaningful intervention is open only during childhood, and every year of unchecked progression adds to your child's long-term risk of serious eye disease. Whether you start with specialty glasses, move to ortho-K, or combine atropine with contact lens therapy, the most important step is getting a proper evaluation from a specialist who focuses on this area.
Texas Contact Lens Institute in Plano, TX brings a well-rated clinical approach to pediatric and adult specialty eye care. Book a consultation and bring your child's most recent prescription history.
